DICLOFENAC

DICLOFENAC was reported 151588 times

DICLOFENAC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUPUS VULGARIS 1018 0.8079
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5642 0.7867
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 521 0.7799
3 SWOLLEN JOINT COUNT INCREASED 2435 0.7628
4 RHEUMATIC FEVER 3386 0.7589
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1469 0.7334
6 DUODENAL ULCER PERFORATION 5310 0.7133
7 HEPATIC ENZYME 106 0.7114
8 C-REACTIVE PROTEIN 605 0.6526
9 GRIP STRENGTH 149 0.6507
10 PEMPHIGUS 8047 0.6430
11 FACET JOINT SYNDROME 2070 0.6352
12 RHEUMATOID FACTOR POSITIVE 3534 0.6112
13 SWOLLEN JOINT COUNT 141 0.5640
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1160 0.5593
15 HAND DEFORMITY 7253 0.5524
16 DISLOCATION OF VERTEBRA 1204 0.5274
17 HYPOCHOLESTEROLAEMIA 185 0.5241
18 HELICOBACTER INFECTION 5220 0.5074
19 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 90 0.5028
20 RETINITIS 868 0.5020
21 X-RAY ABNORMAL 855 0.4777
22 MUSCLE INJURY 3909 0.4713
23 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 261 0.4652
24 EMBOLIA CUTIS MEDICAMENTOSA 345 0.4334
25 FOLLICULITIS 4438 0.4228
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2633 0.4050
27 PERIPHERAL VENOUS DISEASE 1618 0.3958
28 PERICARDITIS 6415 0.3814
29 SERONEGATIVE ARTHRITIS 431 0.3761
30 SYNOVITIS 6673 0.3697
31 INSPIRATORY CAPACITY DECREASED 99 0.3574
32 GLOSSODYNIA 7884 0.3518
33 INTESTINAL DIAPHRAGM DISEASE 91 0.3262
34 C-REACTIVE PROTEIN ABNORMAL 1916 0.2984
35 BREAST CANCER STAGE III 1715 0.2645
36 PORPHYRIA ACUTE 369 0.2571
37 DUCTUS ARTERIOSUS STENOSIS FOETAL 108 0.2535
38 WOUND 7024 0.2510
39 BONE EROSION 855 0.2415
40 LIP DRY 2105 0.2315
41 SYSTEMIC LUPUS ERYTHEMATOSUS 8182 0.2303
42 GRIP STRENGTH DECREASED 2028 0.2302
43 JOINT RANGE OF MOTION DECREASED 2828 0.2107
44 CONTRAINDICATED PRODUCT ADMINISTERED 6379 0.2105
45 ONYCHOMADESIS 882 0.2100
46 BURSITIS 2542 0.2093
47 IRRITABLE BOWEL SYNDROME 4336 0.2020
48 HYPERCHOLESTEROLAEMIA 1927 0.1994
49 DRUG TOLERANCE DECREASED 548 0.1949
50 WOUND INFECTION 2103 0.1918
51 LIVE BIRTH 1563 0.1866
52 DEAFNESS TRANSITORY 152 0.1780
53 OVERLAP SYNDROME 123 0.1757
54 DUCTUS ARTERIOSUS PREMATURE CLOSURE 72 0.1756
55 BLEPHAROSPASM 1072 0.1701
56 ONYCHOMYCOSIS 691 0.1573
57 FIBROMYALGIA 3759 0.1545
58 AUTOIMMUNE DISORDER 1498 0.1535
59 LIVER INJURY 3503 0.1426
60 FINGER DEFORMITY 686 0.1415
61 IMPAIRED HEALING 4498 0.1369
62 NAIL DISORDER 1174 0.1340
63 ARTHROPATHY 7447 0.1338
64 WRIST DEFORMITY 79 0.1285
65 DEATH NEONATAL 178 0.1279
66 TEMPERATURE REGULATION DISORDER 285 0.1278
67 MATERNAL EXPOSURE TIMING UNSPECIFIED 447 0.1189
68 TYPE 2 DIABETES MELLITUS 4003 0.1188
69 RHEUMATOID LUNG 112 0.1173
70 PSORIATIC ARTHROPATHY 4758 0.1171
71 OBESITY 1814 0.1137
72 EXOSTOSIS 1032 0.1129
73 JOINT DESTRUCTION 171 0.1099
74 INFUSION RELATED REACTION 7074 0.1066
75 SCIATICA 1696 0.1063
76 PRESCRIBED OVERDOSE 2041 0.1054
77 GLOMERULONEPHRITIS MINIMAL LESION 76 0.1047
78 PRODUCT LABEL CONFUSION 606 0.1039
79 DISCOMFORT 6216 0.1018
80 SACROILIITIS 188 0.0995
81 COELIAC DISEASE 966 0.0984
82 HEPATIC ENZYME INCREASED 6696 0.0981
83 INFUSION SITE REACTION 291 0.0973
84 HIP ARTHROPLASTY 1491 0.0973
85 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1022 0.0923
86 THERAPEUTIC PRODUCT EFFECT DECREASED 4080 0.0910
87 GASTRIC ULCER PERFORATION 115 0.0907
88 LOWER RESPIRATORY TRACT INFECTION 4112 0.0903
89 LUPUS-LIKE SYNDROME 805 0.0887
90 BACK INJURY 962 0.0884
91 PULMONARY FIBROSIS 1677 0.0873
92 BLISTER 4879 0.0868
93 RHEUMATOID ARTHRITIS 9757 0.0858
94 LOWER LIMB FRACTURE 1638 0.0852
95 WALKING AID USER 561 0.0850
96 OBSTRUCTIVE SLEEP APNOEA SYNDROME 123 0.0843
97 BLOOD CHOLESTEROL INCREASED 3877 0.0831
98 PUSTULAR PSORIASIS 283 0.0823
99 SWELLING 7681 0.0820
100 TENOSYNOVITIS 223 0.0808
101 FOOT DEFORMITY 886 0.0799
102 AXIAL SPONDYLOARTHRITIS 69 0.0785
103 GAIT INABILITY 2579 0.0771
104 OSTEOARTHRITIS 3269 0.0770
105 BREAST CANCER STAGE II 635 0.0762
106 KOUNIS SYNDROME 173 0.0761
107 JOINT DISLOCATION 789 0.0746
108 DRUG INTOLERANCE 7086 0.0733
109 ANKYLOSING SPONDYLITIS 952 0.0722
110 KNEE ARTHROPLASTY 1518 0.0720
111 SPONDYLITIS 262 0.0720
112 FOETAL DEATH 362 0.0697
113 ULCER HAEMORRHAGE 472 0.0697
114 MATERNAL EXPOSURE DURING PREGNANCY 6170 0.0692
115 STOMATITIS 4157 0.0685
116 JOINT SWELLING 8264 0.0684
117 ALLERGY TO CHEMICALS 84 0.0674
118 MYOGLOBIN BLOOD INCREASED 103 0.0673
119 EYE INJURY 197 0.0648
120 NIGHT SWEATS 2080 0.0645
121 PRESCRIBED UNDERDOSE 1277 0.0639
122 C-REACTIVE PROTEIN INCREASED 2325 0.0638
123 DACTYLITIS 62 0.0631
124 ENTHESOPATHY 97 0.0620
125 TREATMENT FAILURE 5137 0.0619
126 MUSCULOSKELETAL STIFFNESS 5360 0.0611
127 FOOD ALLERGY 456 0.0590
128 SYNOVIAL CYST 267 0.0578
129 MOBILITY DECREASED 4093 0.0569
130 CONGENITAL ANOMALY 438 0.0565
131 LIVER FUNCTION TEST INCREASED 1202 0.0559
132 WHEEZING 3313 0.0558
133 RASH VESICULAR 265 0.0548
134 ILL-DEFINED DISORDER 3260 0.0536
135 ABDOMINAL DISCOMFORT 8948 0.0533
136 INJURY 3669 0.0521
137 INFLAMMATION 2680 0.0519
138 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 117 0.0507
139 DRUG TOLERANCE 255 0.0504
140 NORMAL NEWBORN 273 0.0502
141 SHOULDER ARTHROPLASTY 135 0.0501
142 TASTE DISORDER 1015 0.0500
143 BLOOD PRESSURE SYSTOLIC ABNORMAL 121 0.0489
144 MUSCULOSKELETAL PAIN 2564 0.0489
145 BLOOD PRESSURE DIASTOLIC ABNORMAL 124 0.0487
146 EXPOSURE DURING PREGNANCY 2965 0.0477
147 SLEEP DISORDER 3337 0.0472
148 SPINAL FUSION SURGERY 191 0.0470
149 GENERAL PHYSICAL HEALTH DETERIORATION 5380 0.0465
150 GASTROINTESTINAL DISORDER 4147 0.0462
151 OLIGOHYDRAMNIOS 153 0.0458
152 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 786 0.0458
153 HEPATIC CIRRHOSIS 859 0.0457
154 LUNG DISORDER 2226 0.0454
155 ADVERSE REACTION 598 0.0451
156 LARGE INTESTINAL ULCER 122 0.0449
157 OEDEMA 2423 0.0446
158 ROAD TRAFFIC ACCIDENT 1849 0.0442
159 GASTRITIS EROSIVE 205 0.0439
160 DUODENAL ULCER 310 0.0439
161 DRUG-INDUCED LIVER INJURY 1378 0.0439
162 SPINAL STENOSIS 181 0.0438
163 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 802 0.0437
164 PERIORBITAL OEDEMA 226 0.0435
165 LARGE INTESTINAL STENOSIS 87 0.0435
166 ALOPECIA 8451 0.0430
167 POLYARTHRITIS 223 0.0423
168 IMMUNODEFICIENCY 624 0.0418
169 RHEUMATOID NODULE 115 0.0417
170 JOINT STIFFNESS 1088 0.0414
171 DELIRIUM 1425 0.0410
172 CREPITATIONS 122 0.0409
173 INTENTIONAL PRODUCT USE ISSUE 3560 0.0406
174 LIVER DISORDER 1792 0.0404
175 REBOUND ACID HYPERSECRETION 121 0.0400
176 HYPERSENSITIVITY 7375 0.0397
177 EPILEPSY 1191 0.0389
178 EAR INFECTION 1032 0.0387
179 PLANTAR FASCIITIS 128 0.0381
180 PREGNANCY 763 0.0381
181 NEPHROGENIC ANAEMIA 176 0.0380
182 VITAMIN B12 DECREASED 109 0.0378
183 CONTUSION 3617 0.0375
184 SINUSITIS 3809 0.0371
185 SOFT TISSUE INFECTION 67 0.0366
186 DUODENAL ULCER HAEMORRHAGE 104 0.0363
187 HYPERPARATHYROIDISM SECONDARY 90 0.0359
188 PERSONALITY DISORDER 93 0.0355
189 FUNCTIONAL GASTROINTESTINAL DISORDER 120 0.0347
190 INFECTION 4928 0.0340
191 DRY MOUTH 2740 0.0337
192 PERIPHERAL SWELLING 5193 0.0337
193 THERAPY NON-RESPONDER 1498 0.0333
194 BRAIN NATRIURETIC PEPTIDE INCREASED 101 0.0327
195 FIBROSIS 100 0.0325
196 MYOSITIS 291 0.0324
197 NECK PAIN 1803 0.0322
198 GASTRIC ULCER 608 0.0320
199 PEPTIC ULCER 105 0.0316
200 TYPE I HYPERSENSITIVITY 111 0.0315
201 DISABILITY 616 0.0311
202 CHRONIC GASTRITIS 69 0.0305
203 OSTEOPOROSIS 1242 0.0302
204 PRODUCT USE ISSUE 5668 0.0301
205 GENERAL SYMPTOM 225 0.0300
206 CONFUSIONAL STATE 4836 0.0299
207 EAR PAIN 579 0.0298
208 HEPATITIS 750 0.0293
209 FOOT OPERATION 143 0.0289
210 DYSPEPSIA 2790 0.0283
211 NASOPHARYNGITIS 5217 0.0283
212 HYPOAESTHESIA 4226 0.0282
213 MELAENA 619 0.0281
214 GASTROINTESTINAL ULCER 62 0.0279
215 VIRAL UPPER RESPIRATORY TRACT INFECTION 132 0.0277
216 TENDERNESS 289 0.0277
217 GASTRIC PERFORATION 73 0.0268
218 SPINAL PAIN 310 0.0264
219 PHARYNGITIS 328 0.0264
220 MIGRAINE 2501 0.0262
221 UPPER RESPIRATORY TRACT INFECTION 1192 0.0258
222 ABDOMINAL TENDERNESS 128 0.0257
223 HYPERTENSION 5362 0.0253
224 GASTROOESOPHAGEAL REFLUX DISEASE 2020 0.0251
225 INFLAMMATORY MARKER INCREASED 120 0.0242
226 PULMONARY TOXICITY 171 0.0242
227 DUODENITIS 74 0.0241
228 NECROTISING FASCIITIS 83 0.0235
229 BACK DISORDER 382 0.0235
230 SUSPECTED OFF LABEL USE 106 0.0234
231 URTICARIA 3909 0.0233
232 TOXIC EPIDERMAL NECROLYSIS 354 0.0233
233 IRON DEFICIENCY ANAEMIA 214 0.0232
234 ANTINUCLEAR ANTIBODY POSITIVE 74 0.0228
235 JOINT EFFUSION 156 0.0226
236 INTERVERTEBRAL DISC DISORDER 96 0.0225
237 WEIGHT INCREASED 5033 0.0225
238 ARTHRITIS 1765 0.0224
239 UPPER GASTROINTESTINAL HAEMORRHAGE 376 0.0223
240 ARTHRALGIA 9257 0.0222
241 SPINAL OSTEOARTHRITIS 195 0.0222
242 TRICUSPID VALVE INCOMPETENCE 175 0.0220
243 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1032 0.0215
244 RASH 9365 0.0215
245 ASTHMA 2427 0.0215
246 GASTROINTESTINAL PAIN 236 0.0214
247 TUBULOINTERSTITIAL NEPHRITIS 398 0.0212
248 MUSCULAR WEAKNESS 2405 0.0211
249 PAIN 12960 0.0211
250 DIVERTICULUM INTESTINAL 92 0.0210
251 AMNESIA 1366 0.0210
252 INTERVERTEBRAL DISC DEGENERATION 193 0.0208
253 IRON DEFICIENCY 93 0.0207
254 OVERWEIGHT 111 0.0206
255 CONDITION AGGRAVATED 6249 0.0205
256 DYSAESTHESIA 62 0.0202
257 LARGE INTESTINE PERFORATION 140 0.0201
258 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 178 0.0201
259 GASTRIC ULCER HAEMORRHAGE 111 0.0200
260 WEIGHT FLUCTUATION 209 0.0200
261 ARTHRITIS BACTERIAL 81 0.0197
262 MUSCLE SPASTICITY 239 0.0194
263 CHRONIC KIDNEY DISEASE 1470 0.0193
264 ABDOMINAL PAIN UPPER 3980 0.0193
265 SEDATION 506 0.0193
266 MEMORY IMPAIRMENT 2653 0.0193
267 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 326 0.0192
268 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1348 0.0189
269 LYME DISEASE 63 0.0189
270 CONJUNCTIVAL HYPERAEMIA 67 0.0188
271 ANAPHYLACTIC REACTION 1036 0.0187
272 MEDICATION ERROR 1032 0.0185
273 RENAL TUBULAR NECROSIS 181 0.0184
274 RENAL CYST 146 0.0184
275 ONYCHOCLASIS 126 0.0183
276 RESPIRATORY DISORDER 544 0.0182
277 SENSATION OF FOREIGN BODY 153 0.0181
278 BLOOD PRESSURE DIASTOLIC INCREASED 83 0.0180
279 FREQUENT BOWEL MOVEMENTS 480 0.0178
280 NEPHROTIC SYNDROME 119 0.0173
281 PRODUCT USE IN UNAPPROVED INDICATION 4254 0.0171
282 ADVERSE EVENT 1578 0.0171
283 SECRETION DISCHARGE 214 0.0171
284 BLOOD PRESSURE SYSTOLIC INCREASED 333 0.0171
285 DECREASED APPETITE 3883 0.0167
286 TENDON DISORDER 109 0.0167
287 PAIN IN EXTREMITY 4899 0.0166
288 MENISCUS INJURY 102 0.0166
289 OEDEMA PERIPHERAL 2021 0.0166
290 PARAESTHESIA 2595 0.0165
291 ABNORMAL LOSS OF WEIGHT 112 0.0164
292 END STAGE RENAL DISEASE 299 0.0164
293 DYSLIPIDAEMIA 83 0.0163
294 NIGHTMARE 565 0.0163
295 CHEST PAIN 3018 0.0163
296 SKIN NECROSIS 84 0.0162
297 UVEITIS 219 0.0161
298 HAEMATEMESIS 408 0.0161
299 ADRENAL INSUFFICIENCY 194 0.0160
300 PATHOLOGICAL FRACTURE 81 0.0159
301 ANGIOEDEMA 702 0.0159
302 ADVERSE DRUG REACTION 1425 0.0158
303 FLUID RETENTION 805 0.0158
304 PYREXIA 5475 0.0158
305 VAGINAL INFECTION 74 0.0157
306 MUSCLE SPASMS 2866 0.0156
307 VITAMIN D DEFICIENCY 152 0.0156
308 HUMERUS FRACTURE 75 0.0155
309 ERYSIPELAS 78 0.0155
310 GASTRITIS 408 0.0155
311 OLIGURIA 96 0.0154
312 FATIGUE 11967 0.0154
313 GAIT DISTURBANCE 2932 0.0153
314 GROIN PAIN 134 0.0152
315 PSORIASIS 1985 0.0152
316 RASH ERYTHEMATOUS 725 0.0151
317 ATRIAL SEPTAL DEFECT 127 0.0151
318 DEFORMITY 140 0.0150
319 MOVEMENT DISORDER 477 0.0148
320 RECTAL HAEMORRHAGE 630 0.0146
321 NEPHROLITHIASIS 672 0.0146
322 ANURIA 125 0.0145
323 IMPAIRED GASTRIC EMPTYING 197 0.0144
324 INCREASED UPPER AIRWAY SECRETION 74 0.0144
325 INGUINAL HERNIA 87 0.0143
326 BLOOD UREA INCREASED 239 0.0143
327 ANAPHYLACTIC SHOCK 367 0.0142
328 HEPATIC STEATOSIS 265 0.0142
329 MUSCULOSKELETAL DISCOMFORT 241 0.0140
330 ACUTE KIDNEY INJURY 2122 0.0139
331 PURPURA 122 0.0138
332 DECREASED IMMUNE RESPONSIVENESS 135 0.0137
333 DEPRESSION 3122 0.0137
334 WHITE BLOOD CELL COUNT INCREASED 525 0.0137
335 SPINAL DISORDER 129 0.0136
336 GASTRIC HAEMORRHAGE 156 0.0135
337 DIABETIC NEUROPATHY 67 0.0135
338 PRURITUS 5195 0.0135
339 SHOCK HAEMORRHAGIC 110 0.0135
340 OBSTRUCTIVE AIRWAYS DISORDER 150 0.0135
341 PRODUCT ADMINISTRATION INTERRUPTED 105 0.0134
342 MUSCULOSKELETAL CHEST PAIN 206 0.0133
343 SENSITIVITY TO WEATHER CHANGE 70 0.0133
344 RESPIRATORY RATE INCREASED 118 0.0133
345 KLEBSIELLA INFECTION 67 0.0132
346 BRONCHOSPASM 188 0.0132
347 ROTATOR CUFF SYNDROME 169 0.0131
348 SLEEP APNOEA SYNDROME 251 0.0131
349 PRE-EXISTING CONDITION IMPROVED 82 0.0131
350 HIATUS HERNIA 170 0.0131
351 NODULE 170 0.0130
352 RENAL FAILURE ACUTE 552 0.0130
353 RASH MACULO-PAPULAR 289 0.0130
354 BLOOD URIC ACID INCREASED 75 0.0130
355 FACE OEDEMA 219 0.0130
356 DERMATITIS ALLERGIC 163 0.0129
357 FAECALOMA 71 0.0129
358 HYPERKALAEMIA 454 0.0129
359 DIARRHOEA HAEMORRHAGIC 121 0.0129
360 AUTOIMMUNE HEPATITIS 90 0.0129
361 HYPERTRANSAMINASAEMIA 90 0.0129
362 HYPERVENTILATION 75 0.0129
363 VOMITING 6082 0.0129
364 INTERVERTEBRAL DISC PROTRUSION 282 0.0129
365 SKIN LESION 352 0.0128
366 ABDOMINAL DISTENSION 1332 0.0127
367 POSTOPERATIVE WOUND INFECTION 86 0.0127
368 BACK PAIN 2953 0.0127
369 DYSSTASIA 370 0.0127
370 INSOMNIA 3372 0.0126
371 LYMPHOEDEMA 87 0.0126
372 BODY TEMPERATURE INCREASED 255 0.0125
373 PHARYNGEAL SWELLING 122 0.0125
374 FEELING HOT 764 0.0124
375 ULCER 197 0.0124
376 TOOTH ABSCESS 126 0.0124
377 NERVE COMPRESSION 114 0.0123
378 NEPHROPATHY 115 0.0123
379 HYPERAESTHESIA 101 0.0123
380 MUSCULOSKELETAL DISORDER 234 0.0123
381 BRONCHITIS 903 0.0122
382 BLOOD PRESSURE DIASTOLIC DECREASED 90 0.0122
383 MATERNAL EXPOSURE BEFORE PREGNANCY 83 0.0121
384 BLOOD IRON DECREASED 144 0.0121
385 PLATELET COUNT INCREASED 158 0.0121
386 SCOLIOSIS 75 0.0121
387 LEUKOCYTOSIS 219 0.0121
388 INCORRECT PRODUCT ADMINISTRATION DURATION 262 0.0121
389 PNEUMONIA 3888 0.0120
390 ABDOMINAL PAIN 2788 0.0120
391 HYPERHIDROSIS 1531 0.0119
392 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 92 0.0118
393 LYMPHOMA 183 0.0118
394 UNDERDOSE 864 0.0118
395 COLITIS ULCERATIVE 523 0.0117
396 PYELONEPHRITIS 101 0.0116
397 DRUG INTERACTION 1849 0.0116
398 LOWER GASTROINTESTINAL HAEMORRHAGE 86 0.0116
399 FLANK PAIN 109 0.0116
400 OSTEOPENIA 175 0.0115
401 MALAISE 5041 0.0115
402 ASTHENIA 4308 0.0114
403 HEADACHE 7153 0.0114
404 NEPHROPATHY TOXIC 128 0.0114
405 DYSPNOEA 6449 0.0114
406 INJECTION SITE REACTION 782 0.0114
407 CONCOMITANT DISEASE AGGRAVATED 70 0.0113
408 PRODUCT PRESCRIBING ERROR 268 0.0112
409 BONE DENSITY DECREASED 352 0.0112
410 SPLENOMEGALY 131 0.0112
411 TACHYCARDIA 993 0.0112
412 COLITIS ISCHAEMIC 75 0.0111
413 HERPES VIRUS INFECTION 64 0.0111
414 CONCUSSION 86 0.0111
415 CIRCULATORY COLLAPSE 189 0.0111
416 OESOPHAGITIS 121 0.0111
417 BODY TEMPERATURE DECREASED 109 0.0111
418 LEFT VENTRICULAR DYSFUNCTION 74 0.0110
419 DIZZINESS 5491 0.0110
420 THERAPEUTIC RESPONSE DECREASED 665 0.0110
421 DRUG INEFFECTIVE 14387 0.0109
422 SEASONAL ALLERGY 154 0.0109
423 MOUTH ULCERATION 229 0.0109
424 OFF LABEL USE 9500 0.0108
425 STEVENS-JOHNSON SYNDROME 241 0.0108
426 NEURALGIA 263 0.0108
427 FOETAL EXPOSURE DURING PREGNANCY 878 0.0108
428 HYPOPHAGIA 276 0.0108
429 GASTROINTESTINAL HAEMORRHAGE 899 0.0107
430 LIGAMENT SPRAIN 106 0.0107
431 ARTERIOSCLEROSIS CORONARY ARTERY 71 0.0107
432 ESCHERICHIA INFECTION 88 0.0107
433 PULMONARY CONGESTION 141 0.0107
434 ENTERITIS 68 0.0106
435 RENAL INJURY 314 0.0106
436 EOSINOPHILIA 185 0.0105
437 POISONING DELIBERATE 100 0.0105
438 TENDON RUPTURE 130 0.0105
439 CORONARY ARTERY DISEASE 317 0.0105
440 RENAL FAILURE 1384 0.0104
441 HYDRONEPHROSIS 78 0.0104
442 TENDONITIS 161 0.0104
443 VISUAL IMPAIRMENT 1287 0.0104
444 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 267 0.0104
445 CYST 128 0.0103
446 WEIGHT DECREASED 2878 0.0103
447 RASH PRURITIC 558 0.0103
448 METABOLIC ACIDOSIS 329 0.0103
449 JAUNDICE 276 0.0102
450 POST PROCEDURAL INFECTION 83 0.0102
451 FEEDING DISORDER 207 0.0102
452 HAEMATOCHEZIA 562 0.0102
453 RESPIRATORY TRACT INFECTION 265 0.0102
454 LIMB INJURY 276 0.0102
455 GOUT 182 0.0101
456 PRODUCT ODOUR ABNORMAL 106 0.0101
457 RIB FRACTURE 207 0.0101
458 PERITONITIS 208 0.0100
459 ANKLE FRACTURE 155 0.0100
460 DYSPNOEA EXERTIONAL 377 0.0100
461 JOINT INJURY 213 0.0100
462 BLOOD ALBUMIN DECREASED 79 0.0099
463 URINE OUTPUT DECREASED 87 0.0099
464 BLOOD PRESSURE FLUCTUATION 238 0.0099
465 INTENTIONAL PRODUCT MISUSE 868 0.0099
466 ACUTE MYOCARDIAL INFARCTION 292 0.0099
467 FAECES DISCOLOURED 214 0.0099
468 FOOT FRACTURE 187 0.0099
469 LABORATORY TEST ABNORMAL 291 0.0099
470 CORONAVIRUS INFECTION 65 0.0098
471 SEROTONIN SYNDROME 188 0.0098
472 ERYTHEMA MULTIFORME 91 0.0097
473 HYPOCALCAEMIA 184 0.0097
474 GASTROENTERITIS VIRAL 175 0.0097
475 SKIN ULCER 248 0.0096
476 HYPERLIPIDAEMIA 114 0.0095
477 HYPOKINESIA 138 0.0095
478 ECCHYMOSIS 65 0.0095
479 LACTIC ACIDOSIS 307 0.0095
480 DIARRHOEA 6109 0.0095
481 MITRAL VALVE INCOMPETENCE 107 0.0094
482 PALLOR 257 0.0094
483 HEAD DISCOMFORT 166 0.0094
484 PANCREATITIS 494 0.0093
485 LIMB DISCOMFORT 289 0.0093
486 HAND FRACTURE 66 0.0093
487 DEAFNESS 243 0.0093
488 NAUSEA 7321 0.0092
489 BREAST MASS 62 0.0092
490 ACUTE HEPATIC FAILURE 126 0.0092
491 BLOOD MAGNESIUM DECREASED 79 0.0091
492 PNEUMOTHORAX 145 0.0091
493 OSTEOMYELITIS 165 0.0091
494 ANXIETY 2577 0.0090
495 ARTERIOSCLEROSIS 85 0.0090
496 CARPAL TUNNEL SYNDROME 126 0.0090
497 DENTAL CARIES 99 0.0089
498 HEART RATE DECREASED 313 0.0089
499 SCRATCH 94 0.0089
500 ARTHROPOD BITE 66 0.0089
501 MUSCLE STRAIN 77 0.0089
502 THERMAL BURN 63 0.0089
503 GLOMERULAR FILTRATION RATE DECREASED 109 0.0089
504 GASTROENTERITIS 129 0.0088
505 DECUBITUS ULCER 72 0.0088
506 QUALITY OF LIFE DECREASED 118 0.0088
507 INTENTIONAL OVERDOSE 564 0.0088
508 EATING DISORDER 187 0.0088
509 SHOCK 201 0.0087
510 SPINAL COMPRESSION FRACTURE 72 0.0087
511 HYPOKALAEMIA 401 0.0087
512 ELECTROCARDIOGRAM ABNORMAL 68 0.0087
513 SENSORY DISTURBANCE 139 0.0087
514 RENAL IMPAIRMENT 727 0.0086
515 FALL 2868 0.0086
516 INFLAMMATORY BOWEL DISEASE 84 0.0086
517 CHOLECYSTITIS 102 0.0086
518 SKIN LACERATION 93 0.0085
519 FACIAL PAIN 76 0.0085
520 CHOLELITHIASIS 279 0.0085
521 HYPOALBUMINAEMIA 66 0.0085
522 BLOOD CREATININE INCREASED 552 0.0084
523 CYSTITIS 268 0.0084
524 CONJUNCTIVITIS 156 0.0084
525 KIDNEY INFECTION 165 0.0084
526 POOR VENOUS ACCESS 87 0.0084
527 HAEMODIALYSIS 70 0.0083
528 ABDOMINAL PAIN LOWER 210 0.0083
529 POLYURIA 68 0.0083
530 BLOOD ALKALINE PHOSPHATASE INCREASED 205 0.0082
531 SCAR 141 0.0082
532 BODY HEIGHT DECREASED 88 0.0082
533 OROPHARYNGEAL DISCOMFORT 74 0.0082
534 SUICIDE ATTEMPT 496 0.0082
535 POOR QUALITY SLEEP 176 0.0082
536 GAMMA-GLUTAMYLTRANSFERASE INCREASED 181 0.0082
537 TACHYPNOEA 111 0.0082
538 MULTI-ORGAN FAILURE 141 0.0081
539 PRODUCT QUALITY ISSUE 1106 0.0081
540 AFFECTIVE DISORDER 64 0.0081
541 APHTHOUS ULCER 63 0.0081
542 HEPATOCELLULAR INJURY 115 0.0081
543 TOOTH LOSS 168 0.0081
544 RHABDOMYOLYSIS 336 0.0080
545 THROMBOCYTOPENIA 901 0.0080
546 ORAL CANDIDIASIS 106 0.0080
547 OROPHARYNGEAL PAIN 743 0.0080
548 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 235 0.0080
549 PERIPHERAL COLDNESS 110 0.0080
550 HYPONATRAEMIA 451 0.0080
551 PHOTOPHOBIA 150 0.0080
552 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 437 0.0080
553 ECONOMIC PROBLEM 120 0.0079
554 ANHEDONIA 208 0.0079
555 DRY EYE 395 0.0079
556 BLOOD LACTATE DEHYDROGENASE INCREASED 125 0.0079
557 POLYNEUROPATHY 94 0.0078
558 DRUG EFFECT LESS THAN EXPECTED 116 0.0078
559 SKIN HAEMORRHAGE 116 0.0078
560 GASTROINTESTINAL INFECTION 70 0.0078
561 DRUG ERUPTION 138 0.0078
562 HAEMATOMA 201 0.0078
563 ORAL HERPES 151 0.0077
564 MYOCARDIAL ISCHAEMIA 88 0.0077
565 STAPHYLOCOCCAL INFECTION 254 0.0077
566 PAIN IN JAW 218 0.0077
567 ILEUS 95 0.0076
568 KNEE OPERATION 75 0.0076
569 CATARACT 452 0.0076
570 HAEMOGLOBIN DECREASED 779 0.0076
571 SKIN DISORDER 253 0.0076
572 NOCTURIA 92 0.0076
573 COAGULOPATHY 126 0.0076
574 ATELECTASIS 73 0.0075
575 URINARY RETENTION 252 0.0075
576 BLOOD POTASSIUM INCREASED 122 0.0075
577 FACIAL PARALYSIS 64 0.0075
578 INTESTINAL PERFORATION 84 0.0075
579 BLOOD URINE PRESENT 142 0.0075
580 GASTRIC DISORDER 256 0.0075
581 SKIN REACTION 105 0.0074
582 ALANINE AMINOTRANSFERASE INCREASED 457 0.0074
583 DIVERTICULITIS 206 0.0074
584 SEPTIC SHOCK 323 0.0074
585 CANDIDA INFECTION 125 0.0074
586 LOCALISED INFECTION 179 0.0074
587 OXYGEN SATURATION DECREASED 415 0.0074
588 PRODUCTIVE COUGH 352 0.0074
589 METASTASES TO LUNG 85 0.0073
590 MICTURITION URGENCY 84 0.0073
591 SWOLLEN TONGUE 229 0.0073
592 ACUTE RESPIRATORY FAILURE 141 0.0073
593 SKIN INFECTION 82 0.0073
594 ASPIRATION 80 0.0073
595 MIDDLE INSOMNIA 136 0.0073
596 CHROMATURIA 164 0.0073
597 DECREASED ACTIVITY 78 0.0072
598 INTENTIONAL SELF-INJURY 146 0.0072
599 VASCULITIS 84 0.0072
600 MUSCLE TWITCHING 166 0.0072
601 INTERNATIONAL NORMALISED RATIO INCREASED 205 0.0072
602 METASTASES TO BONE 118 0.0072
603 BONE DISORDER 131 0.0072
604 HERPES ZOSTER 412 0.0072
605 ANAEMIA 1364 0.0071
606 EYELID OEDEMA 83 0.0071
607 CELLULITIS 357 0.0071
608 SPINAL OPERATION 87 0.0071
609 URINARY INCONTINENCE 209 0.0070
610 SNEEZING 158 0.0070
611 LYMPHADENOPATHY 249 0.0070
612 HEMIPARESIS 119 0.0070
613 HEPATOMEGALY 69 0.0070
614 INITIAL INSOMNIA 72 0.0070
615 SCAB 80 0.0070
616 COLITIS 265 0.0070
617 SINUS CONGESTION 94 0.0070
618 ABSCESS 111 0.0070
619 MUSCLE RIGIDITY 83 0.0069
620 DERMATITIS CONTACT 79 0.0069
621 NERVE INJURY 77 0.0069
622 CHEST DISCOMFORT 709 0.0069
623 BLOOD PRESSURE INCREASED 1057 0.0069
624 TOOTH FRACTURE 76 0.0069
625 RESTLESS LEGS SYNDROME 125 0.0069
626 COLD SWEAT 121 0.0069
627 PULMONARY HYPERTENSION 143 0.0069
628 PARAESTHESIA ORAL 99 0.0069
629 COVID-19 PNEUMONIA 81 0.0069
630 BLADDER DISORDER 68 0.0068
631 POISONING 86 0.0068
632 IMMUNE SYSTEM DISORDER 90 0.0068
633 HAEMORRHOIDS 133 0.0068
634 HAEMATOCRIT DECREASED 135 0.0068
635 URINARY TRACT INFECTION 1160 0.0068
636 MASS 95 0.0068
637 EYE PAIN 383 0.0068
638 GENERALISED OEDEMA 84 0.0068
639 LIVER FUNCTION TEST ABNORMAL 197 0.0068
640 ANGINA PECTORIS 194 0.0068
641 CARDIOMEGALY 83 0.0067
642 LOSS OF CONSCIOUSNESS 864 0.0067
643 HYPOTHYROIDISM 215 0.0067
644 LIP SWELLING 224 0.0067
645 LEUKOPENIA 336 0.0067
646 APPLICATION SITE RASH 92 0.0067
647 PRODUCT ADMINISTRATION ERROR 135 0.0067
648 DISSEMINATED INTRAVASCULAR COAGULATION 94 0.0067
649 BURNING SENSATION 468 0.0067
650 EYE SWELLING 248 0.0067
651 PHOTOSENSITIVITY REACTION 110 0.0067
652 BLOOD PRESSURE DECREASED 441 0.0066
653 HALLUCINATION, VISUAL 140 0.0066
654 SINUS TACHYCARDIA 94 0.0066
655 TINNITUS 303 0.0066
656 BONE PAIN 386 0.0066
657 CONSTIPATION 1437 0.0066
658 SPINAL FRACTURE 132 0.0066
659 FEMUR FRACTURE 204 0.0066
660 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
661 MYALGIA 1117 0.0066
662 POST PROCEDURAL COMPLICATION 126 0.0066
663 DISORIENTATION 260 0.0066
664 COORDINATION ABNORMAL 91 0.0065
665 PNEUMONITIS 177 0.0065
666 TEMPERATURE INTOLERANCE 67 0.0065
667 BLOOD CALCIUM DECREASED 73 0.0065
668 IMPAIRED WORK ABILITY 138 0.0064
669 RESPIRATORY DEPRESSION 79 0.0064
670 BIPOLAR DISORDER 70 0.0064
671 INCONTINENCE 68 0.0064
672 SOMNOLENCE 1294 0.0064
673 BLOOD SODIUM DECREASED 121 0.0064
674 ILLNESS 661 0.0064
675 RENAL PAIN 68 0.0064
676 CLOSTRIDIUM DIFFICILE COLITIS 68 0.0064
677 RED BLOOD CELL COUNT DECREASED 183 0.0064
678 IMPAIRED QUALITY OF LIFE 92 0.0064
679 ERYTHEMA 1312 0.0064
680 PLEURAL EFFUSION 388 0.0064
681 ORTHOSTATIC HYPOTENSION 111 0.0064
682 DEPRESSED LEVEL OF CONSCIOUSNESS 252 0.0064
683 HAEMATURIA 217 0.0063
684 ASPARTATE AMINOTRANSFERASE INCREASED 336 0.0063
685 NASAL CONGESTION 371 0.0063
686 DYSURIA 232 0.0063
687 CYANOSIS 99 0.0063
688 DYSPHONIA 368 0.0063
689 SMALL INTESTINAL OBSTRUCTION 77 0.0062
690 NEUTROPHIL COUNT INCREASED 64 0.0062
691 TRANSAMINASES INCREASED 138 0.0062
692 CARDIOVASCULAR DISORDER 157 0.0062
693 HYPERBILIRUBINAEMIA 64 0.0062
694 WRIST FRACTURE 74 0.0062
695 APHONIA 86 0.0062
696 EAR DISCOMFORT 63 0.0061
697 OVERDOSE 1313 0.0061
698 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
699 EYE HAEMORRHAGE 81 0.0061
700 RASH PAPULAR 136 0.0061
701 HYPOTENSION 1214 0.0060
702 PANCREATITIS ACUTE 136 0.0060
703 PULMONARY OEDEMA 270 0.0060
704 RETCHING 128 0.0060
705 PELVIC PAIN 109 0.0060
706 PROTEINURIA 114 0.0060
707 HYPERCALCAEMIA 74 0.0060
708 INFLUENZA 666 0.0060
709 INTENTIONAL DOSE OMISSION 170 0.0060
710 HYPOMAGNESAEMIA 83 0.0060
711 MYOCLONUS 71 0.0059
712 HYPERTENSIVE CRISIS 66 0.0059
713 BASAL CELL CARCINOMA 92 0.0059
714 DIPLOPIA 153 0.0059
715 DRUG LEVEL INCREASED 97 0.0059
716 SEPSIS 653 0.0058
717 TOOTH INFECTION 77 0.0058
718 MUSCLE ATROPHY 74 0.0058
719 HEPATOTOXICITY 130 0.0058
720 APATHY 85 0.0058
721 HEAD INJURY 184 0.0058
722 TRANSIENT ISCHAEMIC ATTACK 196 0.0058
723 VERTIGO 354 0.0058
724 TOOTH DISORDER 129 0.0058
725 COUGH 1624 0.0058
726 SYNCOPE 579 0.0058
727 BRAIN OEDEMA 73 0.0058
728 DIABETES MELLITUS 440 0.0058
729 CEREBRAL INFARCTION 141 0.0058
730 PRESYNCOPE 140 0.0058
731 AGRANULOCYTOSIS 107 0.0058
732 MUCOSAL INFLAMMATION 150 0.0057
733 DRUG TOXICITY 78 0.0057
734 THERAPEUTIC RESPONSE SHORTENED 189 0.0057
735 TOOTHACHE 103 0.0057
736 RENAL DISORDER 265 0.0057
737 SWELLING FACE 370 0.0057
738 POST PROCEDURAL HAEMORRHAGE 66 0.0057
739 ERUCTATION 109 0.0056
740 PERICARDIAL EFFUSION 130 0.0056
741 PREMATURE BABY 169 0.0056
742 PNEUMONIA ASPIRATION 140 0.0056
743 ELECTROLYTE IMBALANCE 65 0.0056
744 RESPIRATORY FAILURE 405 0.0055
745 BRADYCARDIA 293 0.0055
746 PROSTATIC SPECIFIC ANTIGEN INCREASED 76 0.0055
747 SPEECH DISORDER 289 0.0055
748 PULMONARY MASS 82 0.0055
749 DEHYDRATION 734 0.0055
750 BLOOD BILIRUBIN INCREASED 148 0.0055
751 THROAT TIGHTNESS 148 0.0055
752 TOXICITY TO VARIOUS AGENTS 921 0.0055
753 LETHARGY 314 0.0055
754 DYSPHAGIA 517 0.0054
755 ACUTE RESPIRATORY DISTRESS SYNDROME 96 0.0054
756 BLOOD POTASSIUM DECREASED 163 0.0054
757 RHINORRHOEA 349 0.0054
758 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 968 0.0054
759 PALPITATIONS 629 0.0054
760 HYPOXIA 189 0.0054
761 INFUSION SITE PAIN 69 0.0053
762 SKIN DISCOLOURATION 246 0.0053
763 SINUS DISORDER 106 0.0053
764 BALANCE DISORDER 462 0.0053
765 HEPATIC FUNCTION ABNORMAL 199 0.0053
766 EYE DISORDER 175 0.0053
767 MULTIPLE ORGAN DYSFUNCTION SYNDROME 150 0.0053
768 CARDIOMYOPATHY 78 0.0053
769 RESTLESSNESS 193 0.0053
770 HAEMOPTYSIS 147 0.0053
771 THERAPY PARTIAL RESPONDER 82 0.0053
772 SURGERY 308 0.0052
773 INJECTION SITE WARMTH 108 0.0052
774 GLAUCOMA 101 0.0052
775 MENTAL DISORDER 228 0.0052
776 VIRAL INFECTION 174 0.0052
777 TOOTH EXTRACTION 65 0.0052
778 THYROID DISORDER 80 0.0052
779 COMA 247 0.0052
780 APPLICATION SITE PAIN 114 0.0052
781 HOT FLUSH 389 0.0052
782 CHOLESTASIS 99 0.0052
783 MYDRIASIS 66 0.0051
784 TREMOR 852 0.0051
785 CHILLS 601 0.0051
786 TREATMENT NONCOMPLIANCE 279 0.0051
787 LYMPHOPENIA 72 0.0051
788 MALIGNANT MELANOMA 68 0.0051
789 DYSARTHRIA 191 0.0051
790 INTESTINAL OBSTRUCTION 191 0.0051
791 OCULAR HYPERAEMIA 240 0.0051
792 SOPOR 67 0.0051
793 PRURITUS GENERALISED 109 0.0050
794 PARALYSIS 72 0.0050
795 ECZEMA 263 0.0050
796 ATRIAL FIBRILLATION 489 0.0050
797 DELUSION 78 0.0050
798 LUNG INFECTION 78 0.0050
799 DISTURBANCE IN ATTENTION 270 0.0050
800 UPPER LIMB FRACTURE 99 0.0050
801 RESPIRATORY DISTRESS 137 0.0050
802 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 259 0.0050
803 INTERSTITIAL LUNG DISEASE 240 0.0050
804 PRODUCT USE COMPLAINT 78 0.0049
805 FLATULENCE 280 0.0049
806 HEART RATE INCREASED 489 0.0049
807 APHASIA 149 0.0049
808 MULTIPLE FRACTURES 81 0.0049
809 THERAPEUTIC RESPONSE UNEXPECTED 221 0.0049
810 HALLUCINATION 367 0.0049
811 BRAIN FOG 76 0.0048
812 DYSKINESIA 197 0.0048
813 RESPIRATORY TRACT CONGESTION 77 0.0048
814 HEPATIC FAILURE 146 0.0048
815 HYPERSOMNIA 138 0.0048
816 ANOREXIA 62 0.0048
817 FEELING ABNORMAL 1145 0.0048
818 DERMATITIS 100 0.0048
819 BACTERIAL INFECTION 89 0.0048
820 UNRESPONSIVE TO STIMULI 123 0.0048
821 BLINDNESS UNILATERAL 67 0.0047
822 HEART RATE IRREGULAR 107 0.0047
823 DRUG ABUSE 394 0.0047
824 PULMONARY EMBOLISM 449 0.0047
825 PANCYTOPENIA 264 0.0047
826 ENCEPHALOPATHY 116 0.0047
827 SUICIDAL IDEATION 431 0.0047
828 MUSCLE TIGHTNESS 76 0.0047
829 DEPRESSED MOOD 248 0.0047
830 CARDIAC ARREST 387 0.0047
831 THROAT IRRITATION 210 0.0047
832 DEVICE RELATED INFECTION 72 0.0047
833 MENTAL IMPAIRMENT 113 0.0047
834 ORAL PAIN 104 0.0046
835 RASH MACULAR 162 0.0046
836 POLLAKIURIA 193 0.0046
837 PHARYNGEAL OEDEMA 71 0.0046
838 GINGIVAL BLEEDING 63 0.0046
839 LOCAL SWELLING 80 0.0046
840 NEUROPATHY PERIPHERAL 435 0.0046
841 FUNGAL INFECTION 152 0.0046
842 LACRIMATION INCREASED 137 0.0045
843 CARDIAC FAILURE 364 0.0045
844 EXPIRED PRODUCT ADMINISTERED 150 0.0045
845 FRACTURE 85 0.0045
846 VISION BLURRED 612 0.0045
847 DEEP VEIN THROMBOSIS 289 0.0044
848 ARRHYTHMIA 210 0.0044
849 ISCHAEMIC STROKE 79 0.0044
850 HERNIA 85 0.0044
851 FEELING COLD 122 0.0044
852 PRODUCT DOSE OMISSION IN ERROR 124 0.0044
853 HYPERGLYCAEMIA 159 0.0044
854 COVID-19 761 0.0043
855 OSTEONECROSIS 142 0.0043
856 HIP FRACTURE 139 0.0043
857 HYPOAESTHESIA ORAL 65 0.0043
858 INFLUENZA LIKE ILLNESS 352 0.0043
859 BLOOD PRESSURE ABNORMAL 85 0.0043
860 PROCEDURAL PAIN 118 0.0042
861 ERECTILE DYSFUNCTION 109 0.0042
862 HALLUCINATION, AUDITORY 67 0.0042
863 HAEMORRHAGE 438 0.0042
864 AGEUSIA 104 0.0042
865 WHITE BLOOD CELL COUNT DECREASED 446 0.0041
866 LYMPHOCYTE COUNT DECREASED 72 0.0041
867 EYE IRRITATION 234 0.0041
868 THROMBOSIS 327 0.0041
869 RESPIRATORY ARREST 112 0.0041
870 HOSPITALISATION 622 0.0040
871 RASH GENERALISED 104 0.0040
872 EMOTIONAL DISTRESS 484 0.0040
873 IRRITABILITY 239 0.0040
874 COMPLETED SUICIDE 330 0.0040
875 ASCITES 116 0.0039
876 NERVOUSNESS 205 0.0039
877 PANIC ATTACK 143 0.0039
878 AGITATION 288 0.0039
879 BLOOD TRIGLYCERIDES INCREASED 69 0.0039
880 CEREBRAL HAEMORRHAGE 138 0.0039
881 ACCIDENTAL OVERDOSE 141 0.0039
882 DRUG EXPOSURE DURING PREGNANCY 131 0.0038
883 EPISTAXIS 288 0.0038
884 CLOSTRIDIUM DIFFICILE INFECTION 83 0.0038
885 SKIN EXFOLIATION 318 0.0038
886 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 763 0.0038
887 PRODUCT PRESCRIBING ISSUE 82 0.0038
888 FLUSHING 382 0.0038
889 FEAR 101 0.0038
890 COGNITIVE DISORDER 175 0.0037
891 ALTERED STATE OF CONSCIOUSNESS 81 0.0037
892 FEELING JITTERY 71 0.0037
893 CARDIAC DISORDER 348 0.0037
894 PARANOIA 64 0.0037
895 HYPOGLYCAEMIA 180 0.0037
896 ABASIA 91 0.0037
897 METASTASES TO LIVER 64 0.0036
898 NEOPLASM MALIGNANT 243 0.0036
899 PRODUCT DOSE OMISSION ISSUE 1069 0.0036
900 INCREASED APPETITE 69 0.0036
901 MULTIPLE SCLEROSIS 172 0.0036
902 GALLBLADDER DISORDER 64 0.0036
903 MOOD SWINGS 113 0.0035
904 MALIGNANT NEOPLASM PROGRESSION 362 0.0035
905 BLINDNESS 143 0.0035
906 ANGER 118 0.0035
907 NERVOUS SYSTEM DISORDER 108 0.0035
908 DYSTONIA 67 0.0035
909 CRYING 125 0.0034
910 OSTEONECROSIS OF JAW 85 0.0034
911 WITHDRAWAL SYNDROME 144 0.0034
912 FULL BLOOD COUNT DECREASED 69 0.0034
913 SEIZURE 394 0.0034
914 PSYCHOTIC DISORDER 99 0.0033
915 DISEASE RECURRENCE 159 0.0033
916 VISUAL ACUITY REDUCED 111 0.0033
917 EYE PRURITUS 112 0.0033
918 CHOKING 65 0.0033
919 CARDIO-RESPIRATORY ARREST 138 0.0033
920 DYSGEUSIA 244 0.0033
921 DISEASE PROGRESSION 388 0.0033
922 MYOCARDIAL INFARCTION 567 0.0032
923 SKIN FISSURES 63 0.0032
924 PAIN OF SKIN 86 0.0032
925 PLATELET COUNT DECREASED 336 0.0031
926 MENTAL STATUS CHANGES 87 0.0031
927 APPLICATION SITE ERYTHEMA 82 0.0031
928 DRUG RESISTANCE 80 0.0031
929 INJECTION SITE SWELLING 238 0.0031
930 DEVICE MALFUNCTION 217 0.0031
931 INJECTION SITE BRUISING 246 0.0031
932 THERAPY INTERRUPTED 220 0.0031
933 MOOD ALTERED 83 0.0030
934 CONVULSION 170 0.0030
935 PRODUCT COMPLAINT 75 0.0030
936 DRUG EFFECT INCOMPLETE 107 0.0029
937 SKIN CANCER 63 0.0029
938 INJECTION SITE ERYTHEMA 362 0.0029
939 INJECTION SITE PRURITUS 195 0.0029
940 HYPOACUSIS 125 0.0029
941 NEUTROPHIL COUNT DECREASED 118 0.0029
942 PRODUCT SUBSTITUTION ISSUE 165 0.0029
943 ABNORMAL DREAMS 79 0.0029
944 SKIN IRRITATION 131 0.0029
945 UNEVALUABLE EVENT 216 0.0029
946 ABORTION SPONTANEOUS 114 0.0028
947 INJECTION SITE MASS 105 0.0028
948 CEREBROVASCULAR ACCIDENT 481 0.0028
949 ELECTROCARDIOGRAM QT PROLONGED 102 0.0028
950 APPLICATION SITE PRURITUS 64 0.0028
951 PRODUCT DOSE OMISSION 184 0.0028
952 PRODUCT AVAILABILITY ISSUE 64 0.0028
953 INCORRECT DOSE ADMINISTERED 637 0.0028
954 VAGINAL HAEMORRHAGE 121 0.0028
955 EMOTIONAL DISORDER 84 0.0027
956 DEMENTIA 75 0.0027
957 THERAPY CESSATION 136 0.0026
958 FEBRILE NEUTROPENIA 175 0.0026
959 INJECTION SITE PAIN 790 0.0026
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 182 0.0026
961 GASTRIC CANCER 63 0.0025
962 NEUTROPENIA 338 0.0025
963 LUNG NEOPLASM MALIGNANT 101 0.0025
964 GLYCOSYLATED HAEMOGLOBIN INCREASED 62 0.0025
965 INCORRECT DRUG ADMINISTRATION DURATION 67 0.0024
966 INJECTION SITE RASH 73 0.0024
967 NEOPLASM PROGRESSION 82 0.0024
968 AGGRESSION 118 0.0024
969 DRUG EFFECT DECREASED 125 0.0023
970 MULTIPLE SCLEROSIS RELAPSE 155 0.0023
971 ACCIDENTAL EXPOSURE TO PRODUCT 233 0.0023
972 DRY SKIN 301 0.0023
973 CARDIAC FAILURE CONGESTIVE 180 0.0022
974 NEEDLE ISSUE 65 0.0022
975 DERMATITIS ATOPIC 117 0.0022
976 BLOOD GLUCOSE INCREASED 414 0.0022
977 INJECTION SITE HAEMORRHAGE 167 0.0021
978 SKIN BURNING SENSATION 141 0.0020
979 DEVICE ISSUE 173 0.0019
980 WRONG TECHNIQUE IN DRUG USAGE PROCESS 70 0.0019
981 NO ADVERSE EVENT 344 0.0019
982 DRUG WITHDRAWAL SYNDROME 154 0.0018
983 ABNORMAL BEHAVIOUR 67 0.0017
984 DEATH 1451 0.0017
985 PROSTATE CANCER 130 0.0016
986 PLASMA CELL MYELOMA 62 0.0016
987 BLOOD GLUCOSE DECREASED 75 0.0016
988 BREAST CANCER 137 0.0015
989 DRUG DOSE OMISSION 241 0.0015
990 ACNE 101 0.0013
991 DRUG DEPENDENCE 208 0.0013
992 PRODUCT STORAGE ERROR 80 0.0009